Cinven is reviewing strategic options for laboratory-services company Synlab International GmbH including a potential sale, people with knowledge of the matter said.
The private equity firm has been speaking with potential advisers and could start a sale process early next year, the people said, asking not to be identified because the information is private. Cinven plans to seek a valuation of about 5.5 billion euros ($6 billion) including debt for Augsburg, Germany-based Synlab, one of the people said.
A sale of Synlab would likely attract other private equity firms, the people said. No final decision has been made, and Cinven could elect to keep the business, the people said. A spokeswoman for Cinven declined to comment, while Synlab didn’t answer phone calls seeking comment.
Cinven first invested in Synlab in June 2015, buying a majority stake from fellow private equity firm BC Partners for about 1.7 billion euros, Bloomberg News reported at the time. It combined the business with Labco SA, which it agreed to buy earlier that year for 1.2 billion euros.
Synlab, led by Chief Executive Officer Mathieu Floreani, also counts Novo A/S and Ontario Teachers’ Pension Plan as minority investors, according to its website. It operates across more than 40 countries, handling more than 500 million clinical tests annually, according to Synlab’s website.
Cinven also owns stakes in retailer Kurt Geiger and German drugmaker Stada Arzneimittel AG, according to its website.
The sale plan comes at a time when Cinven’s rival Apax Partners is also weighing a sale of diagnostic services business Unilabs. The buyout firm is working with advisers at Rothschild & Co. to look at options for the business, people familiar with the matter said last week.
Source: Bloomberg
Can’t stop reading? Read more
KKR invests in Family Doctor with $300m deal to fuel expansion
KKR invests in Family Doctor with $300m deal to fuel expansion Private equity giant KKR acquired a stake in Australian primary care network Family Doctor in a deal worth up to $300m.The agreement, which includes an initial $170m investment, will see Family Doctor...
Update: BlackRock completes acquisition of Preqin to strengthen private markets capabilities
Update: BlackRock completes acquisition of Preqin to strengthen private markets capabilities BlackRock finalised its acquisition of Preqin, integrating the private markets data provider into its operations while maintaining it as an independent offering. This move...
ICG Strategic Equity closes record $11bn fund to expand GP-led secondaries investments
ICG Strategic Equity closes record $11bn fund to expand GP-led secondaries investments ICG secured $11bn for its fifth GP-led secondaries fund, ICG Strategic Equity Fund V, surpassing its $6bn target and more than doubling the size of its previous fund, which closed...